Two Top Stories of NYSE: Geron Corporation (NASDAQ:GERN), Kinross Gold Corporation (NYSE:KGC)

Geron Corporation (NASDAQ:GERN)

The shares of Geron Corporation (NASDAQ:GERN) started off the last trading session with the price of $4.3 while closing the day with the price of $4.19. The shares of Geron Corporation (NASDAQ:GERN) Fell -3.46% with the Loss of -0.11 points.

The shares of Geron Corporation (NASDAQ:GERN) traded with the day volume of 6.96 Million shares whereas its average trading volume is 3.15 Million.

While analyzing the past performance of the stock we can see that the shares of Geron Corporation (NASDAQ:GERN) Gain 40.6% in the last week while rising 76.05% in the last month. Past quarter performance shows the green light with 111.62%. The semi-annual and annual performance shows 90.45% and 98.58% respectively.

Some critical values of the shares of Geron Corporation (NASDAQ:GERN) to be discussed here are: the beta which shows the value at 2.98 while Average True Range of Geron Corporation (NASDAQ:GERN) demonstrate the value at 0.29. The weekly and monthly volatility of the shares of Geron Corporation (NASDAQ:GERN) are indicated at 12.56% and 7.90%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 82.8.

While studying the financial position of the shares of Geron Corporation (NASDAQ:GERN), we can see that the Market capitalization of the company is at 688.92 Million. The shares outstanding for the company is 164.42 Million and the shares float stands at 158.38 Million. The income of the company stand at -29000000 while the sales stand at 1 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.18, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 688.92, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -0.282.


Kinross Gold Corporation (NYSE:KGC)

Kinross Gold Corporation (NYSE:KGC) started its previous trading session at $3.66 and closed at $3.6 showing a Fell of -1.64 Percent.

The Company traded with an average Volume of 10.31 Million whereas, its Day Volume stood at 6.88 Million.

Looking at the performance of the stock, Kinross Gold Corporation (NYSE:KGC) Gain 0.28% in the last week in its shares price and -8.63% in the last month. Quarterly performance shows a red of -10.89 Percent while Semi-Annual and Annual performances shows a -20.53 and 3.75 percent respectively.

Beta for Kinross Gold Corporation (NYSE:KGC) stands at 0.39 while the ATR (average true range) is at 0.13. The Stock’s Weekly and Monthly Volatility is 2.56% and 2.99% respectively showing a RSI value of 41.27.

While studying the financial position of the shares of Kinross Gold Corporation (NYSE:KGC), we can see that the Market capitalization of the company is at 4.53 Billion. The shares outstanding for the company is 1.26 Billion and the shares float stands at 1.25 Billion.

The Company generated an income of 445.4 Million and the sales of 3.3 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.35 a share. P/E (price to earnings) and P/S (price to sales) values are 10.17 and 1.37 respectively.

The Return on Assets stands at 0.055, ROE shows a value of 0.101 and ROI for Kinross Gold Corporation (NYSE:KGC) is 0.072 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment